Orphenadrine Citrate Injection Shortage
Last Updated: July 16, 2024
Status: Current
Products Affected - Description
-
- Orphenadrine Citrate solution for injection, Hikma, 30 mg/mL, 2 mL vial, 10 count, NDC 00641-6182-10
- Orphenadrine Citrate solution for injection, Sagent, 30 mg/mL, 2 mL vial, 10 count, NDC 25021-0651-02
Reason for the Shortage
-
- Hikma did not provide a reason for the shortage.
- Sagent did not provide a reason for the shortage.
Available Products
-
- There are no presentations available
Estimated Resupply Dates
-
- Hikma has orphenadrine 30 mg/mL 2 mL vials on back order and the company estimates a release date of late-July to early-August 2024.
- Sagent has orphenadrine 30 mg/mL 2 mL vials on back order and the company estimates a release date of August 2024.
Updated
Created July 16, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.